PEOPLE - ZymeTx (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Biotechnology company ZymeTx (Oklahoma City, Oklahoma), a developer of products for the diagnosis and treatment of viral disease, has appointed Fred Hiller acting chief financial officer. Mr Hiller succeeds Carl Gibson, who is stepping down as the company's vice-president, controller and treasurer.